Literature DB >> 26121684

Current progress in nanotechnology applications for diagnosis and treatment of kidney diseases.

Sue Hyun Lee1, Jung Bok Lee1, Min Soo Bae2, Daniel A Balikov1, Amy Hwang1, Timothy C Boire1, Il Keun Kwon3, Hak-Joon Sung1, Jae Won Yang4,5.   

Abstract

Significant progress has been made in nanomedicine, primarily in the form of nanoparticles, for theranostic applications to various diseases. A variety of materials, both organic and inorganic, have been used to develop nanoparticles with promise to achieve improved efficacy in medical applications as well as reduced systemic side effects compared to current standard of care medical practices. In particular, this article highlights the recent development and application of nanoparticles for diagnosing and treating nephropathologies.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  drug delivery; kidney disease; nanoparticles; podocyte

Mesh：

Substances：

Year:  2015        PMID： 26121684      PMCID： PMC4874338          DOI： 10.1002/adhm.201500177

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN： 2192-2640            Impact factor:   9.933


  115 in total

1.  Nanogel formation consisting of DNA and poly(amido amine) dendrimer studied by static light scattering and atomic force microscopy.

Authors:  Atanu Mitra; Toyoko Imae
Journal:  Biomacromolecules       Date:  2004 Jan-Feb       Impact factor: 6.988

2.  Gold nanoparticle sensors for detecting chronic kidney disease and disease progression.

Authors:  Ophir Marom; Farid Nakhoul; Ulrike Tisch; Ala Shiban; Zaid Abassi; Hossam Haick
Journal:  Nanomedicine (Lond)       Date:  2012-03-08       Impact factor: 5.307

Review 3.  Epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  J Am Soc Nephrol       Date:  1998-12       Impact factor: 10.121

Review 4.  Nanoparticle systems as tools to improve drug delivery and therapeutic efficacy.

Authors:  Deepa Mishra; Justin R Hubenak; Anshu B Mathur
Journal:  J Biomed Mater Res A       Date:  2013-07-22       Impact factor: 4.396

Review 5.  Chitosan mediated targeted drug delivery system: a review.

Authors:  Manish P Patel; Ravi R Patel; Jayvadan K Patel
Journal:  J Pharm Pharm Sci       Date:  2010       Impact factor: 2.327

Review 6.  Nanocarriers for delivery of platinum anticancer drugs.

Authors:  Hardeep S Oberoi; Natalia V Nukolova; Alexander V Kabanov; Tatiana K Bronich
Journal:  Adv Drug Deliv Rev       Date:  2013-10-08       Impact factor: 15.470

Review 7.  Chitosan-based nanoparticles for tumor-targeted drug delivery.

Authors:  M Prabaharan
Journal:  Int J Biol Macromol       Date:  2014-11-03       Impact factor: 6.953

Review 8.  Dendrimers as high relaxivity MR contrast agents.

Authors:  Michelle R Longmire; Mikako Ogawa; Peter L Choyke; Hisataka Kobayashi
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-10-23

9.  Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores.

Authors:  Hisataka Kobayashi; Satomi Kawamoto; Sang-Kyung Jo; Henry L Bryant; Martin W Brechbiel; Robert A Star
Journal:  Bioconjug Chem       Date:  2003 Mar-Apr       Impact factor: 4.774

10.  Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent.

Authors:  Philippe Bourrinet; Howard H Bengele; Bruno Bonnemain; Anne Dencausse; Jean-Marc Idee; Paula M Jacobs; Jerome M Lewis
Journal:  Invest Radiol       Date:  2006-03       Impact factor: 6.016
View more
  5 in total

Review 1.  Folate-mediated chemotherapy and diagnostics: An updated review and outlook.

Authors:  Leyuan Xu; Qianming Bai; Xin Zhang; Hu Yang
Journal:  J Control Release       Date:  2017-02-22       Impact factor: 9.776

Review 2.  A review of the application of nanoparticles in the diagnosis and treatment of chronic kidney disease.

Authors:  Yanhong Ma; Fanghao Cai; Yangyang Li; Jianghua Chen; Fei Han; Weiqiang Lin
Journal:  Bioact Mater       Date:  2020-06-15

3.  2-Methoxyestradiol TPGS Micelles Attenuate Cyclosporine A-Induced Nephrotoxicity in Rats through Inhibition of TGF-β1 and p-ERK1/2 Axis.

Authors:  Mohammed W Al-Rabia; Mohamed A Alfaleh; Hani Z Asfour; Waleed S Alharbi; Mohamed A El-Moselhy; Nabil A Alhakamy; Usama A Fahmy; Osama A A Ahmed; Omar Fahmy; Omar M Rashad; Abdulmohsin J Alamoudi; Ashraf B Abdel-Naim
Journal:  Antioxidants (Basel)       Date:  2022-07-30

Review 4.  Nanotechnology: a promising method for oral cancer detection and diagnosis.

Authors:  Xiao-Jie Chen; Xue-Qiong Zhang; Qi Liu; Jing Zhang; Gang Zhou
Journal:  J Nanobiotechnology       Date:  2018-06-11       Impact factor: 10.435

Review 5.  Role of Nanotechnology and Their Perspectives in the Treatment of Kidney Diseases.

Authors:  J P Jose Merlin; Xiaogang Li
Journal:  Front Genet       Date:  2022-01-05       Impact factor: 4.599
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.